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EDITORIAL

There’s No Place Like Home

A

dmission of failure is difficult for any of
us, but it is more acutely felt when we
fail our patients, despite our best and sometimes heroic efforts. Failure to thrive may occur
in end-stage renal disease patients undergoing
conventional hemodialysis therapy and not
infrequently. Missed treatments, repeatedly
shortened therapies attributed to intradialytic
hypotension, and myriad other reasons prevent attainment of dialysis adequacy and eventuate in quantitatively and qualitatively poor
outcomes for patients. For those who fail to
thrive with conventional hemodialysis, there
remain options. Transitioning to peritoneal
dialysis is rarely considered in such circumstances, but it represents a feasible alternative.
Indeed, home hemodialysis may constitute
the optimal solution for such patients. Importantly, a patient does not need to be doing
poorly to opt for this solution.
In this issue of Advances in Chronic Kidney
Disease, the success of model programs that
have implemented home-based therapies is
featured. Guest Editors Lok and Chan have collated a series of articles by authors with international renown in the field of home dialytic
therapies, as either home hemodialysis or peritoneal dialysis. This collection articulates the
state-of-the-art of these important chronic kidney replacement therapies. Regarding peritoneal dialysis, the challenges of modality
selection and maintaining a prevalent perito-
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neal dialysis population are outlined. As well,
the importance of provider education in this
modality is stressed. Insofar as home hemodialysis is concerned, it is critical to realize that
this modality is not new.
Essentially, home-based dialytic therapy in
many countries came to a point of near extinction beginning in the late 1970s. In many countries, where hemodialysis was conducted on
a large-scale basis, the availability of home hemodialysis was expediently reduced to a minimum. Enforced attrition of home hemodialysis
became the natural consequence of facilitybased implementations of in-center hemodialysis. Notably, controlling the environment in
which dialytic care was rendered exerted a degree of patient adherence, paternalism aside. In
addition, significant advancements in peritoneal dialysis had the unanticipated effect of
further reducing any impetus to extend the future of home hemodialysis. However, in Australia and New Zealand, this devolution of
home-based therapy did not take place because of the sufficient foresight and funding
to continue this form of kidney failure therapy
in these countries. There, home hemodialysis
continued and was refined during the next 2
decades.
Coincident with these events, the implementation and revival of home-based hemodialysis occurred in other sectors of the world,
particularly Canada. The excellent clinical
outcomes attributed to home hemodialysis
promulgated its own resurgence. Whether the
superior clinical endpoints achieved by this
modality obtained solely from its intrinsically
longer treatment times and, correspondingly,
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enhanced dialytic adequacy, is conjectural but
difficult to dispute. Moreover, patient self-determination, collaboration in the care process,
and adherence were enhanced by home hemodialysis, all ‘‘win-win’’ situations for the patient
and provider. Furthermore, home hemodialysis
appears to confer a survival benefit.
Intensive home hemodialysis in Canada, as
either nocturnal hemodialysis or daily short
hemodialysis, has been associated with superior clinical outcomes. Improvements in blood
pressure control and cardiac function have accrued from intensified therapy, and similar results are achievable in home hemodialysis
patients elsewhere. However, is such a practice
financially reconcilable in health care systems
that are entrenched in facility-based hemodialysis management schemes? Maybe, and the
economic realities of home hemodialysis,
viewed from the ‘‘10,000-foot level,’’ are juxtaposed against the importance of patient selfdetermination and patient-centered care in
this review. In addition, the technological
advances that may spur the growth of home
dialytic treatment are also compiled, along
with the health benefits derived from homebased dialytic therapies.
Lastly, sleep, an oft-ignored, soft endpoint,
is improved by home dialytic treatment. Although Sir William Shakespeare wrote, ‘‘To
sleep perchance to dream,’’ this is far from
what we offer patients undergoing conventional hemodialytic therapy. Sleep impairment
characterizes this end-stage renal disease
population. Sleep disturbances occur during
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the progression of uremia and improve after
the initiation of kidney replacement therapy
but incompletely. In addition, sleep apnea, obstructive and nonobstructive; symptoms of
heart failure; and discontinuities in personal
schedules all contribute to abnormal sleep patterns, in particular truncation of total rapid
eye movement sleep. Consequently, the quality of sleep is reduced, aggravating sleep deprivation and its attendant complications.
Three times a week, maintenance hemodialysis patients incur a time burden of 15 to
20 hours per week devoted to traveling to
and from dialysis centers and undergoing dialytic procedures. The time commitment is
rigidly defined by the center’s schedule, and,
consequently, patient sleep patterns become a
function of the dialysis schedule rather than
natural biorhythms. This is easily confirmed
when one observes fully a quarter of in-center
patients sleeping during their treatments. Intensive home hemodialysis can substantially
improve sleep, and sleep improvement should
be considered one criterion for transitioning
patients to this modality.
Like voters, patients vote with their feet.
Perhaps, after appraising this compendium,
in this age of patient centeredness, we will encourage more of our end-stage kidney patients
to ‘‘stay home’’ for their peritoneal dialysis or
hemodialysis treatments. We may all sleep the
better for it.
Jerry Yee, MD
Editor

